Smith Mark Alan
SEC CIK 1677452 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | Chief MEDICAL Off | 19.9K | — | — | 3 | 2021-06-30 | 2022-06-30 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
Smith Mark Alan made no open-market trades at VTGN in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-15 | 2022-06-30 | VTGN | Vistagen Therapeutics, Inc. | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $0.75 | +5,000 | 19.9K | +34% | +$3,750 | |
| 2022-01-03 | 2021-12-31 | VTGN | Vistagen Therapeutics, Inc. | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $1.66 | +2,655 | 14.9K | +22% | +$4,407 | |
| 2021-07-02 | 2021-06-30 | VTGN | Vistagen Therapeutics, Inc. | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $1.95 | +2,260 | 12.3K | +23% | +$4,407 |
Purchase Sale Sale after option exercise All abbreviations